Skip to main content

Table 3 Logistic regression analysis of predictors of mortality in 59 adults with HIV treated for pulmonary tuberculosis in Jos, Nigeria

From: Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

  Unadjusted Analysis Adjusted Analysis
  OR 95% CI P-value AOR 95% CI P-value
Xpert positive 0.32 0.08–1.32 0.12 0.67 0.11–4.05 0.66
Age, years 1.03 0.97–1.10 0.19 1.04 0.96–1.12 0.31
BMI < 18.5 Kg/m2 1.90 0.41–8.82 0.41 - - -
Sex, Female 4.52 0.87–23.50 0.07 5.63 0.69–45.93 0.11
3 or more TB symptoms 0.66 0.11–3.81 0.65 - - -
Recent CD4 count <200 cells/mm3 0.87 0.21–3.50 0.84 - - -
Recent CD4 count (cell/mm3) 1.00 0.99–1.00 0.66 - - -
On ART 0.11 0.02–0.77 0.03 0.10 0.01–0.93 0.04
Time to treatment (days) 0.99 0.95–1.05 0.87 - - -
  1. OR Odds ratio, AOR Adjusted odds ratio, CI Confidence interval, BMI Body mass index, TB tuberculosis, ART Antiretroviral therapy
  2. Variables with p < 0.2 in the bivariate analysis were included in the adjusted model